Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Brief Reports

Citations 31-40 of 1234 total displayed.

Past content (since Jul 1999):

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors
Simona Soverini, Alessandra Gnani, Sabrina Colarossi, Fausto Castagnetti, Elisabetta Abruzzese, Stefania Paolini, Serena Merante, Ester Orlandi, Silvia de Matteis, Antonella Gozzini, Ilaria Iacobucci, Francesca Palandri, Gabriele Gugliotta, Cristina Papayannidis, Angela Poerio, Marilina Amabile, Daniela Cilloni, Gianantonio Rosti, Michele Baccarani, and Giovanni Martinelli
Blood 2009; 114: 2168-2171. [Abstract] [Full text] [PDF]  

Genetic evidence for a predominant role of PI3Kβ catalytic activity in ITAM- and integrin-mediated signaling in platelets
Ilaria Canobbio, Lucia Stefanini, Lina Cipolla, Elisa Ciraolo, Cristian Gruppi, Cesare Balduini, Emilio Hirsch, and Mauro Torti
Blood 2009; 114: 2193-2196. [Abstract] [Full text] [PDF]  

Definitive proof for direct reprogramming of hematopoietic cells to pluripotency
Motohito Okabe, Makoto Otsu, Dong Hyuck Ahn, Toshihiro Kobayashi, Yohei Morita, Yukiko Wakiyama, Masafumi Onodera, Koji Eto, Hideo Ema, and Hiromitsu Nakauchi
Blood 2009; 114: 1764-1767. [Abstract] [Full text] [PDF]  

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Mignon L. Loh, Debbie S. Sakai, Christian Flotho, Michelle Kang, Manfred Fliegauf, Sophie Archambeault, Charles G. Mullighan, Leslie Chen, Eva Bergstraesser, Carlos E. Bueso-Ramos, Peter D. Emanuel, Henrik Hasle, Jean-Pierre Issa, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Jan Stary, Monica Trebo, Marcin Wlodarski, Marco Zecca, Kevin M. Shannon, and Charlotte M. Niemeyer
Blood 2009; 114: 1859-1863. [Abstract] [Full text] [PDF]  

Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations
Bénédicte Dumont, Dominique Lasne, Chantal Rothschild, Maxime Bouabdelli, Véronique Ollivier, Claire Oudin, Nadine Ajzenberg, Bernard Grandchamp, and Martine Jandrot-Perrus
Blood 2009; 114: 1900-1903. [Abstract] [Full text] [PDF]  

Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101–positive antigen-presenting cells
Gholamreza Anani Sarab, Michael Moss, Robert N. Barker, and Stanislaw J. Urbaniak
Blood 2009; 114: 1954-1957. [Abstract] [Full text] [PDF]  

Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms
Cécile Saint-Martin, Gwendoline Leroy, François Delhommeau, Gérard Panelatti, Sabrina Dupont, Chloé James, Isabelle Plo, Dominique Bordessoule, Christine Chomienne, André Delannoy, Alain Devidas, Martine Gardembas-Pain, Françoise Isnard, Yves Plumelle, Olivier Bernard, William Vainchenker, Albert Najman, Christine Bellanné-Chantelot, and the French Group of Familial Myeloproliferative Disorders
Blood 2009; 114: 1628-1632. [Abstract] [Full text] [PDF]  

Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation
Claudio Graziano, Simona Carone, Emanuele Panza, Flora Marino, Pamela Magini, Giovanni Romeo, Andrea Pession, and Marco Seri
Blood 2009; 114: 1655-1657. [Abstract] [Full text] [PDF]  

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols
Martin Stanulla, Elke Schaeffeler, Anja Möricke, Sally A. Coulthard, Gunnar Cario, André Schrauder, Peter Kaatsch, Michael Dördelmann, Karl Welte, Martin Zimmermann, Alfred Reiter, Michel Eichelbaum, Hansjörg Riehm, Martin Schrappe, and Matthias Schwab
Blood 2009; 114: 1314-1318. [Abstract] [Full text] [PDF]  

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
Pablo Ramirez, Michael P. Rettig, Geoffrey L. Uy, Elena Deych, Matthew S. Holt, Julie K. Ritchey, and John F. DiPersio
Blood 2009; 114: 1340-1343. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124

* Sign up for Collection Alerts

* Collected Resources Home

* Related collections:
 Special Departments
 ASH 50th Anniversary Reviews
 e-Blood
 Blood Work
 Brief Reports
 Controversies in Hematology
 Focus on Hematology
 Free Research Articles
 How I Treat
 Perspectives
 Plenary Papers
 Review Articles
 Reviews in Translational Hematology

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020